SG156690A1 - Mammalian genes involved in infection - Google Patents

Mammalian genes involved in infection

Info

Publication number
SG156690A1
SG156690A1 SG200907248-9A SG2009072489A SG156690A1 SG 156690 A1 SG156690 A1 SG 156690A1 SG 2009072489 A SG2009072489 A SG 2009072489A SG 156690 A1 SG156690 A1 SG 156690A1
Authority
SG
Singapore
Prior art keywords
infection
genes involved
mammalian genes
sequences
involved
Prior art date
Application number
SG200907248-9A
Other languages
English (en)
Inventor
Donald H Rubin
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36228473&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG156690(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Publication of SG156690A1 publication Critical patent/SG156690A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
SG200907248-9A 2004-10-27 2005-10-27 Mammalian genes involved in infection SG156690A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62248604P 2004-10-27 2004-10-27

Publications (1)

Publication Number Publication Date
SG156690A1 true SG156690A1 (en) 2009-11-26

Family

ID=36228473

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200907248-9A SG156690A1 (en) 2004-10-27 2005-10-27 Mammalian genes involved in infection

Country Status (8)

Country Link
US (1) US7964346B2 (fr)
EP (2) EP1812597A2 (fr)
JP (1) JP2008520191A (fr)
CN (1) CN101115846A (fr)
AU (1) AU2005299296A1 (fr)
CA (1) CA2585970A1 (fr)
SG (1) SG156690A1 (fr)
WO (1) WO2006047673A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200911290A (en) * 2007-07-02 2009-03-16 Alcon Res Ltd RNAI-mediated inhibition of HTRA1 for treatment of macular degeneration
US20130067609A1 (en) * 2009-06-12 2013-03-14 Donald Rubin Mammalian Genes Involved in Tularemia and Other Infections
US20140220690A1 (en) * 2009-11-11 2014-08-07 Vanderbilt University Mammalian genes involved in infection
WO2012045067A2 (fr) * 2010-10-01 2012-04-05 Zirus, Inc. Gènes de mammifères impliqués dans l'infection
CA2866392C (fr) 2012-03-30 2023-10-24 Washington University Procedes de modulation de l'expression de tau pour reduire l'avc et modifier un symptome neurodegeneratif
RU2745324C2 (ru) 2013-03-14 2021-03-23 Ионис Фармасьютикалз, Инк. Композиции и способы модулирования экспрессии tau
TWI772856B (zh) * 2013-07-19 2022-08-01 美商百健Ｍａ公司 用於調節τ蛋白表現之組合物
AU2014362262B2 (en) * 2013-12-12 2021-05-13 Alnylam Pharmaceuticals, Inc. Complement component iRNA compositions and methods of use thereof
GB201400309D0 (en) * 2014-01-08 2014-02-26 Aqua Gen As Predicting Resistance to disease
SG11201607038TA (en) * 2014-03-04 2016-09-29 Sigma Aldrich Co Llc Viral resistant cells and uses thereof
JOP20190065A1 (ar) 2016-09-29 2019-03-28 Ionis Pharmaceuticals Inc مركبات وطرق لتقليل التعبير عن tau
WO2019089922A1 (fr) 2017-11-01 2019-05-09 Alnylam Pharmaceuticals, Inc. Compositions d'arni de composant du complément c3 et leurs procédés d'utilisation
EP3543340A1 (fr) * 2018-03-19 2019-09-25 Fundació Centre de Regulació Genòmica Oligonucléotides antisens et leurs utilisations
CN115552006A (zh) * 2020-03-18 2022-12-30 马萨诸塞大学 用于mapt调节的寡核苷酸
CN111450251B (zh) * 2020-03-23 2021-11-26 清华大学 Mthfd1抑制剂在抑制和杀灭病毒中的应用
WO2022197607A2 (fr) * 2021-03-14 2022-09-22 Sirnaomics, Inc. Procédés de traitement du cancer par administration d'arnsi contre bclxl et mcl1 à l'aide d'une nanoparticule polypeptidique
WO2023076451A1 (fr) 2021-10-29 2023-05-04 Alnylam Pharmaceuticals, Inc. Compositions d'arni du facteur b du complément (cfb) et leurs procédés d'utilisation

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4980286A (en) 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US4902505A (en) 1986-07-30 1990-02-20 Alkermes Chimeric peptides for neuropeptide delivery through the blood-brain barrier
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US4904582A (en) 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
AU7623194A (en) 1993-09-03 1995-03-22 Vpi Holdings Ltd. Oligonucleotides with rna cleavage activity
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6974666B1 (en) 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5859308A (en) 1994-12-29 1999-01-12 University Of Medicine And Denistry Of New Jersey Transgenic animals and related aspects
US5599695A (en) 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
AU2253397A (en) 1996-01-23 1997-08-20 Affymetrix, Inc. Nucleic acid analysis techniques
WO1997029212A1 (fr) 1996-02-08 1997-08-14 Affymetrix, Inc. Speciation de micro-organismes a partir de microplaquettes et caracterisation des phenotypes de ceux-ci
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
CA2251818A1 (fr) 1996-04-15 1997-10-23 Vanderbilt University Genes mammiferes impliques dans l'infection virale et la suppression de tumeurs
US6777177B1 (en) 1997-10-10 2004-08-17 Vanderbilt University Mammalian genes involved in viral infection and tumor suppression
US6281408B1 (en) 1998-02-20 2001-08-28 Thomas Jefferson University Efficient method for production of compound transgenic animals
IL141309A0 (en) 1998-08-11 2002-03-10 Univ Hawaii Mammalian transgenesis by intracytoplasmic sperm injection
AU2103601A (en) 1999-12-17 2001-06-25 Oregon Health And Science University Methods for producing transgenic animals
WO2002005634A2 (fr) 2000-07-13 2002-01-24 University Of South Florida Animal transgenique et methodes
AU2001291558A1 (en) 2000-09-06 2002-03-22 Nexia Biotechnologies, Inc. Generation of transgenic animals using nuclear transfer and oocytes at the germinal vesicle stage
WO2002044321A2 (fr) 2000-12-01 2002-06-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Petites molecules d'arn mediant l'interference arn

Also Published As

Publication number Publication date
EP1812597A2 (fr) 2007-08-01
US20080118495A1 (en) 2008-05-22
EP2311530A2 (fr) 2011-04-20
CA2585970A1 (fr) 2006-05-04
WO2006047673A2 (fr) 2006-05-04
AU2005299296A1 (en) 2006-05-04
JP2008520191A (ja) 2008-06-19
CN101115846A (zh) 2008-01-30
US7964346B2 (en) 2011-06-21
WO2006047673A3 (fr) 2007-02-22

Similar Documents

Publication Publication Date Title
SG156690A1 (en) Mammalian genes involved in infection
WO2011008956A3 (fr) Gènes de mammifères impliqués dans une infection
WO2010134939A3 (fr) Gènes de mammifère impliqués dans l'infection
EA201990861A1 (ru) Рнк-направляемые модифицирующие нуклеиновые кислоты ферменты и способы их применения
WO2010039778A3 (fr) Gènes mammaliens intervenant dans une infection
BRPI0519766A2 (pt) proteases Ácidas féngicas
PH12014500829A1 (en) Mutations in oas1 genes
DK2357226T3 (da) Rationelt udformede meganukleaser med ændret sekvensspecificitet og DNA-bindingsaffinitet
TW200611910A (en) Interferon-alpha polypeptides and conjugates
WO2006029258A3 (fr) Chimie medicale utilisant des aptameres
TW200611974A (en) Chimeric adenoviruses for use in cancer treatment
ATE533838T1 (de) Verfahren zur verbesserten einführung von dna in bakterienzellen
WO2010110914A3 (fr) Gènes de mammifère impliqués dans l'infection
WO2011146527A3 (fr) Gènes de mammifères impliqués dans des infections
UA93658C2 (en) Cell surface glycoprotein
WO2007084488A3 (fr) Adam10 et ses utilisations dans l'infection
ATE442382T1 (de) Ein die mam-domäne enthaltendes protein
DK1630232T3 (da) Optimerede nukleotidsekvenser kodende for sgp130
WO2010144908A3 (fr) Gènes de mammifère impliqués dans la tularémie et autres infections
WO2012045067A3 (fr) Gènes de mammifères impliqués dans l'infection
DK1587932T3 (da) Plantetransformation med in vivo samling af et træk
EP1937717A4 (fr) Molécules d'acide nucléique et protéines de pénumbra, et utilisations de ces dernières
ATE403730T1 (de) Gene, die fuer kohlenstoffmetabolismus- und energieproduktions-proteine codieren
EP1792911A4 (fr) Sequence d'acides amines essentielle pour l'expression de genes neurospecifiques
KR20040053279A (ko) 스트레스 저항성 및 내성 단백질을 코딩하는 유전자